Search - tctmd.com

Displaying 161 - 180 of 276

Sort: Relevancy | Date

News Daily News

Nationwide Registry Shows Trends in DES Use Over a Decade

June 02, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

EuroPCR Features PAD Therapies in Early Development and Real-World Use

Caitlin E. Cox

May 21, 2014

News Conference News EuroPCR 2014

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Caitlin E. Cox

May 21, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

News Daily News

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

April 30, 2014

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

News Daily News

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

April 14, 2014

News Conference News ACC 2014

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Yael L. Maxwell

March 31, 2014

Presentation Physiology and Intravascular Imaging 2014

Mechanisms and Predictors of In-stent Restenosis and Stent Thrombosis

Presenter: Soo-Jin Kang

March 27, 2014

News Daily News

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Yael L. Maxwell

February 26, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

Presentation

A Randomized Comparison of drug-eluting balloon (DEB) vs. EES in pts with BMS In-stent Restenosis

Presenter: Fernando Alfonso

January 16, 2014

Presentation TCT 2013

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

Presenter: J?rg Schr?der

October 31, 2013

Presentation TCT 2013

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

Presenter: Fernando Alfonso

October 30, 2013

News Conference News TCT 2013

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

October 30, 2013

Presentation TCT 2013

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

Presenter: Bo Xu

October 29, 2013

Presentation TCT 2013

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

Presenter: Soo-Jin Kang

October 29, 2013

Presentation TCT 2013

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Presenter: Bruno Scheller

October 28, 2013

Advertisement

Nationwide Registry Shows Trends in DES Use Over a Decade

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

EuroPCR Features PAD Therapies in Early Development and Real-World Use

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Long-term Outcomes of ‘Full Metal Jacket’ Stenting Appear Favorable

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Mechanisms and Predictors of In-stent Restenosis and Stent Thrombosis

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

A Randomized Comparison of drug-eluting balloon (DEB) vs. EES in pts with BMS In-stent Restenosis

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

LEVANT 2, RIBS Show Promise for Paclitaxel-Coated Balloons in PAD and CAD

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

PATENT-C: A Prospective, Randomized Trial of a Paclitaxel-Coated Scoring Balloon vs. a Standard Balloon for Treatment of Coronary In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content